drugset / Trial / NCT02748902

Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands.

NCT02748902

Phase 1 Completed 16 enrolled Neal D. Bhatia, MD LEO Pharma · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if ingenol mebutate 0.05% gel is safe and effective in treating common warts on the hands.

Timeline

Start
2016-04-27
Primary completion
2017-01-27
Completion
2017-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject ingenol mebutate Small molecule 0.05 % Topical

Indications